Study | Age(y) | Participants | Disease | BMI | Duration | Exercise program | Dosage of citrulline | Measured outcomes |
---|---|---|---|---|---|---|---|---|
Buckinx ( |
66.9 ± 4.2 | 28M, 28F | - | 30.5 ± 4.5 | 12 weeks; 3x/week | HIIT; 30s 85%HRmax: 90s 65%HRmax; 10sets | 10g/day | ↑LLS ↔BMI; WC; FM; 6MWT; TUG |
Buckinx ( |
67.8 ± 4.2 | 21M, 23F | - | 26.1 ± 2.55 | 12 weeks; 3x/week | HIIT; 30s 85%HRmax: 90s 65%HRmax; 10sets | 10g/day | ↓FM ↑TUG ↔BMI; WC; 6MWT; LLS |
Caballero ( |
65.1 ± 4.0 | 18M, 26F | Sarcopenia | 25.8 ± 2.6 | 6 weeks | AT; RPE14; 10min. RT; RPE16; 20min |
3g/day | ↑6MWT ↔TUG |
Figueroa ( |
58.0 ± 1.0 | 27F | - | 34.4 ± 1.0 | 8 weeks; 3x/week | WBVT; 25-40Hz; OA= 1-2 mm; Semi-squats, wide-stance semi-squats, calf raises and squats; 60s; 5sets; Side-alternating vibrations. | 6g/day | ↔LM; FM; LLS |
Kang (2023) | 62.5 ± 1.5 | 24F | Hypertension | 29.4 ± 1.4 | 4 weeks; 3x/week | RT; Leg press, leg extension, leg curl, and calf raise; 50%1RM; 25min | 10g/day | ↑LM; LLS ↔BMI; WC; FM; |
Marcangeli ( |
67.7 ± 4.5 | 38M, 43F | - | 29.2 ± 4.7 | 12 weeks; 3x/week | HIIT; 30s 85%HRmax: 90s 65%HRmax; 10sets | 10g/day | ↑LLS ↔WC; LM; FM; 6MWT; TUG; |
Wong (2015) | 58.0 ± 3.5 | 27F | - | 34.4 ± 3.7 | 8 weeks; 3x/week | WBVT; 25-40Hz; OA= 1-2 mm; Semi-squats, wide-stance semi-squats, calf raises and squats; 60s; 5sets; Side-alternating vibrations. | 6g/day | ↔BMI |